Breaking Down Mental Health (Season 2) - Episode 3 Psychotropic Medications for Depression

Wednesday, February 21, 2024, 12:00 AM - Saturday, February 20, 2027, 11:44 PM


AMA PRA Category 1 Credits™ (0.50 hours), Non-Physician Attendance (0.50 hours)

Episode 3 Psychotropic Medications for Depression
Featured guest: Amy VandenBerg, PharmD, BCPP

1. Identify appropriate selective serotonin reuptake inhibitors for the management of depression in pediatric patients and how they work.
2. Identify appropriate serotonin-norepinephrine reuptake inhibitors for the management of depression in pediatric patients and how they work.
3. Discuss the black-box warning associated with these medications.
4. Identify symptoms of serotonin syndrome.
5. Identify symptoms of discontinuation syndrome.

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

AMA PRA Category 1  
The University of Michigan Medical School designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions or concerns, please contact: Rebecca Priest

Resources

• Selective serotonin reuptake inhibitors (StatPearls)
•  Demystifying serotonin syndrome (or serotonin toxicity) (Canadian Family Physician)
•  Antidepressant discontinuation syndrome (Canadian Medical Association Journal)
•  Antidepressants and the FDA’s black-box warning: determining a rational public policy in the absence of sufficient evidence (AMA Journal of Ethics)
•  Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison (Innovations in Clinical Neuroscience) 

 

Educational Planner Team:

• Christina Cwynar, DNP, CPNP-PC, PMHNP-BC
• Syma Khan, MSW
• Heidi Burns, MD

Presenters

• Daniel Maixner
  
• Joanna Quigley
  
• Cheryl King  
  
• Alejandra Arango  
  
• Amy VandenBerg  
  
• Dayna Leplatte  
  
• Cody Weston  
  
• Dawn Dore-Stites  

Mitigation of Relevant Financial Relationships

The University of Michigan Medical School adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, or others are required to disclose all relevant financial relationships with ineligible entities. 

All of the relevant financial relationships listed for those individuals have been mitigated.

• Alejandra Arango, PhD, presenter of educational event, is a  Intellectual Property/Royalties holder for Adaptive Testing Technologies.
• Cheryl King, PhD, presenter of educational event, holds a Consultant/Advisory Role for Vita Health.

No other planners or presenters  for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.